Literature DB >> 16040961

Human {beta}-defensin 2 is expressed and associated with Mycobacterium tuberculosis during infection of human alveolar epithelial cells.

Bruno Rivas-Santiago1, Stephan K Schwander, Carmen Sarabia, Gill Diamond, Marcia E Klein-Patel, Rogelio Hernandez-Pando, Jerrold J Ellner, Eduardo Sada.   

Abstract

To determine the role of human beta-defensin 2 (HBD-2) in human tuberculosis, we studied the in vitro induction of HBD-2 gene expression by Mycobacterium tuberculosis H37Rv infection in the human lung epithelial cell line A549, in alveolar macrophages (AM), and in blood monocytes (MN) by reverse transcription-PCR. We also studied the induction of HBD-2 gene expression by mannose lipoarabinomannan (manLAM) from M. tuberculosis. Intracellular production of HBD-2 peptide was detected by immunocytochemistry and electron microscopy. Our results demonstrated that there was induction of HBD-2 mRNA in A549 cells after infection with M. tuberculosis at various multiplicities of infection (MOI) and that there was stimulation with manLAM. AM expressed the HBD-2 gene only at a high MOI with M. tuberculosis. MN did not express HBD-2 at any of the experimental M. tuberculosis MOI. Immunostaining revealed the presence of intracellular HBD-2 peptide in A549 cells following infection with M. tuberculosis, and the staining was more intense in areas where there were M. tuberculosis clusters. By using electron microscopy we also demonstrated production of HBD-2 after M. tuberculosis infection and adherence of HBD-2 to the membranes of M. tuberculosis. Alveolar epithelial cells are among the first cells to encounter M. tuberculosis following aerogenic infection. As HBD-2 has been shown to control growth of M. tuberculosis and has chemotactic activity, our results suggest that HBD-2 induction by M. tuberculosis may have a role in the pathogenesis of human tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16040961      PMCID: PMC1201238          DOI: 10.1128/IAI.73.8.4505-4511.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

1.  Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity.

Authors:  J R García; A Krause; S Schulz; F J Rodríguez-Jiménez; E Klüver; K Adermann; U Forssmann; A Frimpong-Boateng; R Bals; W G Forssmann
Journal:  FASEB J       Date:  2001-08       Impact factor: 5.191

Review 2.  Chemokines meet defensins: the merging concepts of chemoattractants and antimicrobial peptides in host defense.

Authors:  Manuela Dürr; Andreas Peschel
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

3.  Association of polymorphisms in the collagen region of human SP-A1 and SP-A2 genes with pulmonary tuberculosis in Indian population.

Authors:  Taruna Madan; Shweta Saxena; Kolluri J R Murthy; Kambadur Muralidhar; Puranam Usha Sarma
Journal:  Clin Chem Lab Med       Date:  2002-10       Impact factor: 3.694

4.  Human Toll-like receptor 2 mediates induction of the antimicrobial peptide human beta-defensin 2 in response to bacterial lipoprotein.

Authors:  T Birchler; R Seibl; K Büchner; S Loeliger; R Seger; J P Hossle; A Aguzzi; R P Lauener
Journal:  Eur J Immunol       Date:  2001-11       Impact factor: 5.532

5.  Antimycobacterial agent based on mRNA encoding human beta-defensin 2 enables primary macrophages to restrict growth of Mycobacterium tuberculosis.

Authors:  K O Kisich; L Heifets; M Higgins; G Diamond
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

6.  Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6.

Authors:  D Yang; O Chertov; S N Bykovskaia; Q Chen; M J Buffo; J Shogan; M Anderson; J M Schröder; J M Wang; O M Howard; J J Oppenheim
Journal:  Science       Date:  1999-10-15       Impact factor: 47.728

7.  Discovery of five conserved beta -defensin gene clusters using a computational search strategy.

Authors:  Brian C Schutte; Joseph P Mitros; Jennifer A Bartlett; Jesse D Walters; Hong Peng Jia; Michael J Welsh; Thomas L Casavant; Paul B McCray
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

8.  Differential expression of alpha- and beta-defensins in human peripheral blood.

Authors:  X-M Fang; Q Shu; Q-X Chen; M Book; H-G Sahl; A Hoeft; F Stuber
Journal:  Eur J Clin Invest       Date:  2003-01       Impact factor: 4.686

9.  Expression of beta-defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells.

Authors:  Louise A Duits; Bep Ravensbergen; Mirjam Rademaker; Pieter S Hiemstra; Peter H Nibbering
Journal:  Immunology       Date:  2002-08       Impact factor: 7.397

Review 10.  Epithelial antimicrobial peptides in host defense against infection.

Authors:  R Bals
Journal:  Respir Res       Date:  2000-10-20
View more
  52 in total

1.  Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection.

Authors:  Stephan Schwander; Keertan Dheda
Journal:  Am J Respir Crit Care Med       Date:  2010-11-12       Impact factor: 21.405

2.  Air pollution particulate matter alters antimycobacterial respiratory epithelium innate immunity.

Authors:  César E Rivas-Santiago; Srijata Sarkar; Pasquale Cantarella; Álvaro Osornio-Vargas; Raúl Quintana-Belmares; Qingyu Meng; Thomas J Kirn; Pamela Ohman Strickland; Judith C Chow; John G Watson; Martha Torres; Stephan Schwander
Journal:  Infect Immun       Date:  2015-04-06       Impact factor: 3.441

3.  Alveolar epithelial cells are critical in protection of the respiratory tract by secretion of factors able to modulate the activity of pulmonary macrophages and directly control bacterial growth.

Authors:  Olga D Chuquimia; Dagbjort H Petursdottir; Natalia Periolo; Carmen Fernández
Journal:  Infect Immun       Date:  2012-11-12       Impact factor: 3.441

Review 4.  Alveolar Epithelial Cells in Mycobacterium tuberculosis Infection: Active Players or Innocent Bystanders?

Authors:  Julia M Scordo; Daren L Knoell; Jordi B Torrelles
Journal:  J Innate Immun       Date:  2015-09-18       Impact factor: 7.349

5.  LL-37 disrupts the Kaposi's sarcoma-associated herpesvirus envelope and inhibits infection in oral epithelial cells.

Authors:  David C Brice; Zsolt Toth; Gill Diamond
Journal:  Antiviral Res       Date:  2018-08-02       Impact factor: 5.970

6.  Role of human beta-defensin-2 during tumor necrosis factor-alpha/NF-kappaB-mediated innate antiviral response against human respiratory syncytial virus.

Authors:  Srikanth Kota; Ahmed Sabbah; Te Hung Chang; Rosalinda Harnack; Yan Xiang; Xiangzhi Meng; Santanu Bose
Journal:  J Biol Chem       Date:  2008-06-20       Impact factor: 5.157

7.  Differences in virulence and immune response induced in a murine model by isolates of Mycobacterium ulcerans from different geographic areas.

Authors:  R Hurtado Ortiz; D Aguilar Leon; H Orozco Estevez; A Martin; J Luna Herrera; L Flores Romo; F Portaels; R Hernandez Pando
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

8.  Legionella pneumophila induces human beta defensin-3 in pulmonary cells.

Authors:  Stefanie Scharf; Kremena Vardarova; Friederike Lang; Bernd Schmeck; Bastian Opitz; Antje Flieger; Klaus Heuner; Stefan Hippenstiel; Norbert Suttorp; Philippe D N'Guessan
Journal:  Respir Res       Date:  2010-07-08

9.  Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells.

Authors:  Bruno Rivas-Santiago; Rogelio Hernandez-Pando; Claudia Carranza; Esmeralda Juarez; Juan Leon Contreras; Diana Aguilar-Leon; Martha Torres; Eduardo Sada
Journal:  Infect Immun       Date:  2007-12-26       Impact factor: 3.441

10.  Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses.

Authors:  Philip T Liu; Mirjam Schenk; Valencia P Walker; Paul W Dempsey; Melissa Kanchanapoomi; Matthew Wheelwright; Aria Vazirnia; Xiaoran Zhang; Andreas Steinmeyer; Ulrich Zügel; Bruce W Hollis; Genhong Cheng; Robert L Modlin
Journal:  PLoS One       Date:  2009-06-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.